DecisionRx Partners with MotivHealth to Deliver Medication Therapy Optimization to Health Plan Members
Medication Therapy Optimization (MTO) is a precision medicine practice that uses clinical pharmacists, pharmacogenomics, and a sophisticated data-science toolset to reduce the human and financial costs of trial-and-error prescribing
“MotivHealth was founded to break the mold in the insurance market, and DecisionRx is doing the same when it comes to personalizing the approach to medication therapy,” said MotivHealth CEO
Studies show that approximately 40% of prescriptions either don’t work or introduce new medical problems, and these medication failures account for at least 16% of all healthcare costs. Through its data-driven MTO platform, clinically-trained DecisionRx pharmacists equip providers with information and specific recommendations that allow them to more effectively customize medication regimens for each patient.
“We are excited by the opportunity to impact the lives of MotivHealth’s members enrolled in our solution,” said DecisionRx President and Co-Founder
About MotivHealth
MotivHealth is revolutionizing the way people engage with health insurance by focusing on HSA-based insurance plans that produce lower premiums, better benefits, and improved wellness of its members. Motiv has been successfully lowering the costs of healthcare for hundreds of companies since 2015, with a mission to help employers build simple and affordable solutions that empower members to get the most out of their benefits. As a result, Motiv clients have enjoyed annual premium increases of <4% for the last several years. MotivHealth is headquartered in
About DecisionRx
DecisionRx is a technology-enabled healthcare services company, improving patient outcomes and reducing healthcare costs by helping providers optimize prescribing decisions for their patients. DecisionRx clinical pharmacists work on patients’ behalf to mitigate medication failure by making personalized medication recommendations to prescribers, informed by the latest clinical and data-science, and delivered in a value-based care model. Medication failure accounts for at least 16% of total healthcare spending, and medication therapy optimization has been shown to reduce the total annual cost of care by over
View source version on businesswire.com: https://www.businesswire.com/news/home/20241010748447/en/
Media
ICR Westwicke
646-277-1252
[email protected]
Source: DecisionRx
Gold Sales Explode at Costco as Investors Buy 3 Dividend Gold Stocks Hand-Over-Fist
Pete Galla Joins Alliant Insurance Services as Executive Vice President, Alliant M&A
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News